Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Jun;22(3):552-8.
doi: 10.1016/j.conb.2011.10.007. Epub 2011 Oct 28.

Functional regulation of GABAA receptors in nervous system pathologies

Affiliations
Review

Functional regulation of GABAA receptors in nervous system pathologies

Rochelle M Hines et al. Curr Opin Neurobiol. 2012 Jun.

Abstract

Inhibitory neurotransmission is primarily governed by γ-aminobutyric acid (GABA) type A receptors (GABAARs). GABAARs are heteropentameric ligand-gated channels formed by the combination of 19 possible subunits. GABAAR subunits are subject to multiple types of regulation, impacting the localization, properties, and function of assembled receptors. GABAARs mediate both phasic (synaptic) and tonic (extrasynaptic) inhibition. While the regulatory mechanisms governing synaptic receptors have begun to be defined, little is known about the regulation of extrasynaptic receptors. We examine the contributions of GABAARs to the pathogenesis of neurodevelopmental disorders, schizophrenia, depression, epilepsy, and stroke, with particular focus on extrasynaptic GABAARs. We suggest that extrasynaptic GABAARs are attractive targets for the treatment of these disorders, and that research should be focused on delineating the mechanisms that regulate extrasynaptic GABAARs, promoting new therapeutic approaches.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Mechanisms regulating the accumulation of synaptic/phasic and extrasynaptic/tonic GABAARs. The basal GABAA current represents a combination of phasic inhibitory currents in a background of extrasynaptic GABAAR activation. Phasic GABAAR currents (mIPSCs, left panel) arise from the release of GABA-containing vesicles from a presynaptic terminal directly opposed to receptors clustered at the corresponding postsynaptic specialization. In the case of tonic inhibition (right panel), low ambient concentrations of GABA (or other agonists such as taurine), result in tonic activation of high affinity extrasynaptic receptors. The tonic current can be measured by application of a specific GABAA antagonist, which blocks both phasic and tonic channel activity, resulting in a shift of the holding current that can be interpreted as the tonic GABAAR contribution. (Currents shown are schematics.) Both phasic and tonic forms of GABAAR inhibition rely on the appropriate targeting/clustering and function of distinct classes of GABAARs containing α1–3,βx,γ2 and α4–6,βx,δ receptor subunits, respectively. Studies from multiple laboratories have begun to define the mechanisms regulating the accumulation of synaptic GABAARs. The scaffolding protein gephyrin has been indicated as a key player in localizing synaptic GABAARs. In the cytosol, gephyrin exists as a trimer and relies on cooperative interactions with collybistin and neuroligin2 for enrichment at the plasma membrane. The complex of gephyrin–collybistin–neuroligin2, via interaction with presynaptic neurexins, helps to align the postsynaptic specialization with presynaptic GABA-releasing terminals. The clustering of GABAARs in the postsynaptic specialization is facilitated by interaction of specific subunits (α1, α2, α3) with gephyrin. In contrast to synaptic receptors, the proteins interacting with, and regulating the clustering of extrasynaptic receptors are largely unknown. To this point, only radixin has been indicated to interact with the α5 subunit, which is known to be present at extrasynaptic sites.

Similar articles

Cited by

References

    1. Fritschy JM. Epilepsy, E/I balance and GABA(A) receptor plasticity. Front Mol Neurosci. 2008;1:5. - PMC - PubMed
    1. Lydiard RB. The role of GABA in anxiety disorders. J Clin Psychiatry. 2003;64(Suppl. 3):21–27. - PubMed
    1. Craddock N, Jones L, Jones IR, Kirov G, Green EK, Grozeva D, Moskvina V, Nikolov I, Hamshere ML, Vukcevic D, et al. Strong genetic evidence for a selective influence of GABAA receptors on a component of the bipolar disorder phenotype. Mol Psychiatry. 2010;15:146–153. - PMC - PubMed
    1. Luscher B, Shen Q, Sahir N. The GABAergic deficit hypothesis of major depressive disorder. Mol Psychiatry. 2011;16:383–406. - PMC - PubMed
    1. Di Cristo G. Development of cortical GABAergic circuits and its implications for neurodevelopmental disorders. Clin Genet. 2007;72:1–8. - PubMed

Substances